Biomimetic Coatings Functionalized With Adhesion Peptides For Dental Implants
Biomimetic Coatings Functionalized With Adhesion Peptides For Dental Implants
A complete biological integration into the surrounding tissues (bone, gingiva) is a critical
step for clinical success of a dental implant. In this work biomimetic coatings consisting
either of collagen type I (for the gingiva region) and hydroxyapatite (HAP) or mineralized
collagen (for the bone interface) have been developed as suitable surfaces regarding the
interfaces. Additionally, using these biomimetic coatings as a matrix, adhesion peptides
were bound to further increase the speci®city of titanium implant surfaces. To enhance cell
attachment in the gingiva region, a linear adhesion peptide developed from a laminin
sequence (TWYKIAFQRNRK) was bound to collagen, whereas for the bone interface, a cyclic
RGD peptide was bound to HAP and mineralized collagen using adequate anchor systems.
The biological potential of these coatings deduced from cell attachment experiments with
HaCaT human keratinocytes and MC3T3-E1 mouse osteoblasts showed the best results for
collagen and laminin sequence coating for the gingiva region and mineralized collagen and
RGD peptide coatings for regions with bone contact. Our concept opens promising
approaches to improve the biological integration of dental implants.
# 2001 Kluwer Academic Publishers
Collagen coating
Collagen type I coating of Ti6Al4V samples was Adhesion peptides
performed according to Geiûler et al. [26]. Brie¯y, for The linear laminin sequence was synthesized with a thiol
coating with ®brillar collagen (acid soluble calfskin anchor (NMI, TuÈbingen, Germany) and bound to amino
collagen, Fluka, Deisenhofen, Germany) samples were groups of collagen using sulfosuccinimidyl 4-( p-
incubated in a suspension of 65 mM phosphate buffer maleimidophenyl)butyrat (SMPB). The peptide cyclo
( pH 7.0, 25 C) with a collagen concentration of about (-RGDfK) utilized with thiol or phosphonate anchor
1 mg ml 1 for 15 min and rinsed with distilled water. groups [28] was bound to collagen or CPP, respectively.
The binding was performed with concentrations of
0.1 mmol for the RGD peptide and 1 mmol for the
Hydroxyapatite coating laminin sequence in the coating solution, which are in the
The HAP coating on Ti6Al4V was achieved by a two step range of saturation coverage for titanium samples given
process. First HAP was deposited on titanium by an by ELISA measurements.
electrochemically controlled method. The process of Scanning electron microscopy (SEM, DSM 982
deposition is described in detail in Roessler et al. Gemini, Carl Zeiss Oberkochen, Germany) at low
[27]. Brie¯y, cathodic polarization was carried out acceleration voltage (1 kV) was utilized for morphology
using galvanostatic mode 100 A m 2 in a Ca2 = characterization. Fourier Transform Infrared
3 x Spectroscopy (FTS 2000, Perkin-Elmer) was used to
Hx PO4 -containing electrolyte (0.03 M CaCl2
0:02 M NH4 H2 PO4 ) at pH 6.4 and 37 C for 1 h. Second characterize the chemical compositions of the deposited
anodic polarization in phosphate buffer ( pH 12, 36 C) CPP and the mineralized collagen.
using galvanostatic mode 10 A m 2 ; 40 VSCE was Cell attachment was measured in triplicate using
carried out to increase oxide thickness and hence partially hexosaminidase test 1 h after seeding [29]. ELISA
incorporate the HAP layer into the anodic oxide layer. The measurements were related to cell number and enzyme
coated samples were washed in distilled water and dried in activity by measuring absorbance in wells with known
air. number of cells. Plating ef®ciency was calculated
relative to the enzyme activity of the seeded cell
number (50.000).
Mineralized collagen coating
Mineralization of collagen was accomplished by an
electrochemically controlled process in a Ca2 = Results
3 x
Hx PO4 -containing electrolyte at near physiological Morphology and chemical
conditions for pH (6.4) and temperature (36 C) under composition
cathodic polarization of the sample. Prior to mineral- Morphology (SEM) and chemical composition (FTIR) of
ization collagen ®brils were adsorbed onto a HAP layer the biomimetic coatings comprising either collagen,
previously deposited on the titanium surface by an HAP or mineralized collagen are described in the
electrochemically controlled procedure (see above) and following. A polished titanium sample which was used
872
Figure 2 SEM-image of adsorbed collagen type I ®brils on Ti6Al4V.
as reference surface is shown in Fig. 1. Fig. 2 shows a length and 5 60 nm width and height. The HAP needles
titanium surface covered by a network of native collagen form a porous structure with no preferential direction of
®brils after adsorptive immobilization. The characteristic crystallite orientation. The thickness of the coating is
banding pattern of collagen type I ®brils (67 nm) is seen about 5 mm. Fig. 4 shows the mineralized collagen
and a ®bril width between 80±100 nm was measured with coating on a titanium surface. The mineralized collagen
atomic force microscopy (AFM). Due to adsorption, coatings consist basically of a two layer structure
®brils deform and expose a ratio of width to height of comprising a pure layer of HAP on the titanium surface
about 10 which indicates strong interactions with the with a mineralized collagen layer on top. Until complete
titanium surface [30]. Places in between the network of mineralization was achieved the characteristic banding
collagen ®brils appear free of collagen in SEM-images pattern of collagen ®brils (63±67 nm) remained visible.
but are homogenously covered by collagen molecules However, no periodic correlation of HAP crystals c-axes
and small aggregates as found with AFM [31]. It is related to the banding pattern of collagen was found,
important to note, that the titanium surface is homo- instead collagen ®brils are covered by HAP. The
genously covered by collagen either collagen ®brils or electrochemical parameters used here result in partial
small aggregates. The coating consisting of electro- mineralization of the collagen ®brils. The thickness of
chemically prepared HAP is shown in Fig. 3. The HAP the coating is about 4 mm.
crystals have a needle like appearance with 5 500 nm FTIR-spectroscopy has been used to analyze the
873
Figure 4 SEM-image of mineralized collagen type I coating on Ti6Al4V.
chemical composition of the coatings and characteristic characteristic phosphate bands between 1000 and
spectra are shown in Fig. 5. As intensities resulting from 1100 cm 1 as well as the amide-bands and can be
adsorbed collagen ®lms were too low, thick collagen interpreted as a superposition of the two components
®lms were prepared by drying high concentrated HAP and collagen I. For the amide-I-band a broadening
collagen suspension on titanium. The spectrum of and shift to lower wavenumbers was found. FTIR-spectra
collagen I ®brils shows maxima at 1660, 1555 and of bone (cranial bone) are almost similar to our
1280 cm 1 which can be assigned to protein amide-I-, - biomimetic coatings (mineralized collagen). The shift
II-, and -III-bands respectively. The FTIR-spectrum of of the amide-I-band of mineralized collagen corresponds
HAP clearly shows splitting into the antisymmetric v3 to the broad amide-I-band of bone.
and v4 vibration modes (1050, 1090 cm 1 and
570,600 cm 1 . The previously inactive v1 vibration of Cell adhesion
the free phosphate ion can also be seen in the HAP Cell adhesion experiments were carried out with HaCaT
spectrum. Additional bands at 874, 1587 and 1419 cm 1 human keratinocytes and MC3T3-E1 mouse osteoblasts
can be associated to carbonate ions (CO23 ) resulting representing two different cell types in contact with a
from the reaction of OH ions with carbon dioxide from dental implant. Fig. 6 shows the plating ef®ciency for the
air. The characteristic OH libration at 630 cm 1 is also basic coatings of collagen, mineralized collagen and
evident. The OH stretching vibration at 3570 cm 1 is HAP and for the corresponding states with bound
either very weak or, due to the reaction of CO2 with the adhesion peptides. MC3T3-E1 cells were not tested on
hydroxyl groups of the electrochemically controlled surfaces coated with the laminin sequence. According to
deposited HAP, not detectable. It is further conceivable their differentiation stage there is a risk that they express
that the OH stretching vibration is overlapped by a broad the corresponding integrin receptors leading to non-
band resulting from adsorbed water. FTIR- and XRD- speci®c results. For HaCaT cells the strongest in¯uence
spectra of CPP using a electrochemically assisted on cell adhesion is coming from collagen, leading to a
procedure have been published in detail previously plating ef®ciency of 37% for the collagen coating in
[27]. The spectrum of mineralized collagen shows the contrast to 2% for the uncoated control. This is con®rmed
by the mineralized collagen surfaces where values in the
range of 40% are reached, while hydroxyapatite is less
favored with 11%. Binding of the laminin sequence to
the collagen layer leads to a further increase of cell
adhesion (57%). For the mineralized collagen no
in¯uence of the laminin sequence could be observed.
The RGD peptide shows no signi®cant in¯uence on
HaCaT cells except on the hydroxyapatite surface. Cell
adhesion of MC3T3-E1 mouse osteoblasts is improved to
values around 32% for mineralized collagen and HAP
coatings, while the control reaches 5% and the collagen
coating 10%. The binding of the RGD adhesion peptide
in this case also improves the plating ef®ciency leading
Figure 5 FTIR-spectra for hydroxyapatite, collagen type I, mineralized to values above 50% independent on anchor and coating
collagen type I and bone (cranial bone). type.
874
Figure 6 Cell adhesion of MC3T3-E1 and HaCaT cells on different biomimetic coatings and their functionalized surface states: 1 Ti6Al4V reference,
2±4 collagen, 5±8 mineralized collagen, 9±10 hydroxyapatite. Adhesion peptides were bound to collagen (3, 4, 6, 8) or to hydroxyapatite (7, 10).
this case as well as for the laminin sequence on B I T T I N G E R , M . OT T O and C . L . K L E I N , J. Mater. Sci. 8
the chosen cyclic RGD peptide. A high selectivity can and A . H . M E L C H E R , ibid. 9 (1988) 302.
17. D . A . P U L E O and A . N A N C I , ibid. 20 (1999) 2311.
also be deduced from the negligible in¯uence of this 18. S . R O E S S L E R , C . W O L F, D . S C H A R N W E B E R and H . W O R C H ,
peptide on the HaCaT cells. Similar property has also J. Adhes. Sci. Technol. 14 (2000) 453.
been demonstrated by Kantlehner et al. [52] for other cell 19. H . W O R C H in ``Metals as Biomaterials'', edited by J. A. Helsen
types. and H. J.Breme (John Wiley & Sons Ltd, 1998) p. 177.
20. P. S C H A F F N E R , J . M E Y E R , M . D A R D , B . N I E S , S . V E R R I E R ,
H . K E S S L E R and M . K A N T L E H N E R , J. Mater. Sci.: Mater.
Med. 10 (1999) 837.
Conclusion 21. J . P. M A Z Z U CO T E L L I , C . K L E I N - S OY E R , A . B E R E T Z , C .
Biomimetic coatings consisting of the main components B R I S S O N , G . A R C H I P O F F and J . P. CA Z E N AV E , Int. J. Artif.
of bone can be produced on titanium implant surfaces Organs 14 (1991) 482.
22. S . RO E S S L E R , D . S C H A R N W E B E R , R . B O R N , H . WO R C H , A .
using electrochemical controlled methods. SEM and
S E W I N G and M . D A R D , in ``Proceedings of the 6th World
FTIR-spectroscopy of biomimetic coatings show struc- Biomaterials Congress'' (Kamuela, Hawaii, May 2000,
tural and chemical properties comparable to bone. Transactions) p. 1040.
Further, adhesion promoting peptides could be immobi- 23. H . B . W E N , J . R . D E W I J N , F. Z . C U I and K . D E G RO OT,
lized on collagen, HAP or mineralized collagen without J. Biomed. Mater. Res. 41 (1998) 227.
24. M . N O M I Z U , W. H . K I M , K . YA M A M U R A , A . U TA N I and
losing their functionality. Biomimetic coatings can be
S A N G - Y O , J. Biol. Chem. 270 (1995) 20583.
regarded as a good alternative to the conventional 25. M . K A N T L E H N E R , D . F I N S I N G E R , J . M E Y E R , P.
covalent coupling to metallic implant surfaces. Cell S C H A F F N E R , A . J O N C Z Y K , B . D I E F E N B AC H E R , B . N I E S
adhesion experiments provide evidence to our concepts and H . K E S S L E R , Angew. Chem. 111 (1999) 587.
to coat metal implants with the main components of the 26. U . G E I S S L E R , U . H E M P E L , C . W O L F, D . S C H A R N W E B E R ,
H . W O R C H and K . W. W E N Z E L , J. Biomed. Mater. Res. 51
extracellular matrix presenting additionally an adhesion
(2000) 752.
promoting peptide. Coating and adhesion peptide have to 27. S. RO E S S L E R , M. S TO E L Z E L , R. BORN, D.
be chosen regarding to the host tissue at the interface. S C H A R N W E B E R , H . W O R C H , A . S E W I N G and M . D A R D ,
ibid. Submitted May, 2001.
28. A . J O N C Z Y K , S . G O O D M A N , B . D I E F E N B AC H , A . S U T T E R
and H . K E S S L E R , WO-A97/14716.
Acknowledgment 29. U . L A N D E G R E N , J. Immunol. Meth. 67 (1984) 379.
The ®nancial support by BMBF (03N4021) is gratefully 30. S . R O E S S L E R , D . S C H A R N W E B E R and H . W O R C H , J. Mater.
acknowledged. The authors like to thank B. Blessing and Sci. Lett. 18 (1999) 577.
S. Perschbacher for performing the cell experiments and 31. S . R O E S S L E R , C . W O L F, D . S C H A R N W E B E R , H . W O R C H , A .
S E W I N G and M . D A R D , in ``Proceedings of the 6th World
BoneMaster GmbH, Dresden, for providing the hy-
Biomaterials Congress'' (Kamuela, Hawaii, May 2000,
droxyapatite coatings. Transactions) p. 1045.
32. A . N A N C I , J . D . W U E S T, L . P E R U , P. B R U N E T, V. S H A R M A ,
S . Z A L Z A L and M . D . M C K E E , J. Biomed. Mater. Res. 40 (1998)
References 342.
1. M. BRIEN, H. S C H L I E P H A K E , J . B E C K E R and P. A . 33. B . T. H O U S E M A N and M . M R K S I C H , Biomaterials 22 (2001)
R E I C H A R T, Z. ZahnaÈrtzl. Implantol. 14 (1998) 208. 943.
2. D . B U S E R , R . K . S C H E N K , S . S T E I N E M A N N , J . P. 34. S . B A N and S . M A R U N O , J. Biomed. Mater. Res. 42 (1998) 387.
F I O R E L L I N I , C . H . F O X and H . S T I C H , J. Biomed. Mater. 35. H . I S H I Z AWA and M . O G I N O , ibid. 31 (1996) 6279.
Res. 25 (1991) 889. 36. J . R E D E P E N N I N G , T. S C H L E S S I N G E R , S . B U R N H A M , L .
3. G . L . D E L A N G E and K . D O N AT H , Biomaterials 9 (1988) 302. L I P P I E L LO and J . M I Y A N O , ibid. 30 (1996) 287.
4. L . W. L I N D Q U I S T, B . R O C K L E R and G . E . CA R L S S O N , 37. M . S H I R K H A N Z A D E H , J. Mater. Sci.: Mater. Med. 9 (1998)
J. Prosthet. Dent. 59 (1988) 59. 67.
876
38. R . Z . L E G E RO S , in ``Calcium Phosphates in Oral Biology and 47. E . D . H AY, in ``Cell biology of extracellular matrix'' (Plenum
Medicine'' (Basel, KraÈger, 1991) p. 110. Press, New York, 1991) p. 343.
39. J . H . B R A D T, M . M E R T I G , A . T E R E S I A K and W. PO M P E , 48. A. BRUCE, B. DENNIS, L. JULIAN, R. MARTIN, R. KEITH
Chem. Mater. 11 (1999) 2694. and D . W. J A M E S , in ``Molecular biology of the cell'' (Garland,
40. Y. D O I , T. H O R I G U C H I , Y. M O R I WA K I , H . K I I TA G O , T. New York, 1994) p. 963.
K A J I M O T O and Y. J . I . I WAY A M A , J. Biomed. Mater. Res. 31 49. M . K L E I N , T. H O H L F E L D , P. M O O R M A N N and H .
(1996) 43. M E N N E K I N G , Int. J. Oral. Maxillofac. Impl. 15 (2000) 247.
41. C . D U , Z . F. C U I , W. Z H A N G , Q . L . F E N G and K . D E G RO O T , 50. L. RA È ISAÈ NEN, M. KO È NOÈ NEN, J. JUHANOJA, P.
ibid. 50 (1999) 518. VA R P AVA A R A , J . H A U TA N I E M I and M . H O R M I A ,
42. K . S . T E N H I U S E N , R . M A R T I N , M . K L I M K I E W I C Z and P. W. J. Biomed. Mater. Res. 49 (2000) 79.
B RO W N , ibid. 29 (1995) 803. 51. B . D I E F E N B AC H , Ph.D. Thesis, TH Darmstadt, Germany (1995).
43. J . J . H WA N G , K . J A E G E R , J . H A N CO C K and S . I . S T U P P, ibid. 52. M . K A N T L E H N E R , P. S C H A F F N E R , D . F I N S I N G E R ,
47 (1999) 504. J . M E Y E R , A . J O N C Z Y K , B . D I E F E N B AC H E R , B . N I E S , G .
44. A . P. V. A . D E S E R R O , A . C . F E R N A N D E S , B . J . V. HO È L Z E M A N N , S . L . G O O D M A N and H . K E S S L E R ,
S A R A M A G O , J . L I M A and M . A . B A R B O S A , Biomaterials 18 Chembiochem. 1 (2000) 107.
(1997) 963.
45. A . P. V. A . D E S E R R O , A . C . F E R N A N D E S and B . J . V.
S A R A M A G O , J. Biomed. Mater. Res. 49 (2000) 345.
46. M . M R K S I C H and G . M . W H I T E S I D E S , Ann. Rev. Biophys. Received 14 May
Biomol. Struct. 25 (1996) 55. and accepted 21 May 2001
877